Revenue outlook
搜索文档
Stoneridge reaffirms 2026 adjusted EBITDA guidance of $20M-$25M while updating revenue outlook to $645M-$670M (NYSE:SRI)
Seeking Alpha· 2026-05-08 19:02
新闻内容技术访问问题 - 提供的文档内容不包含任何关于公司或行业的实质性信息，仅包含关于浏览器设置的技术提示 [1]
Guardant Health raises 2026 revenue outlook to $1.30B-$1.32B as Shield targets 230,000-245,000 tests (NASDAQ:GH)
Seeking Alpha· 2026-05-08 17:22
新闻内容技术访问问题 - 提供的文档内容仅为一条技术提示，要求用户启用浏览器Javascript和Cookie，或禁用广告拦截器以继续访问，未包含任何实质性的公司或行业新闻、数据、事件或财务信息 [1]
Verra Mobility reaffirms 2026 outlook of $1.02B-$1.03B revenue and $405M-$415M adjusted EBITDA amid $10M annualized cost savings plan (NASDAQ:VRRM)
Seeking Alpha· 2026-05-07 08:32
新闻内容分析 - 提供的文档仅包含技术性提示，要求用户启用浏览器Javascript和Cookie，并可能需禁用广告拦截器以继续访问，文档中未包含任何关于具体公司、行业、市场动态、财务数据或经济事件的实质性内容 [1]
Adtran outlines $283M-$303M Q2 2026 revenue outlook as LiteWave800 targets production in about a year (NASDAQ:ADTN)
Seeking Alpha· 2026-05-06 02:52
To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh. ...
Neuronetics outlines $160M-$166M 2026 revenue outlook with focus on $2.5M-$3M annualized cost savings (NASDAQ:STIM)
Seeking Alpha· 2026-05-06 00:42
技术访问问题 - 用户需在浏览器中启用Javascript和Cookies以确保未来正常访问 [1] - 启用广告拦截器可能导致访问受阻 用户需禁用广告拦截器并刷新页面以继续 [1]
Medifast reconfirms $270M-$300M 2026 revenue outlook as it targets profitability improvements starting in Q4 2026 (NYSE:MED)
Seeking Alpha· 2026-05-05 06:55
To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh. ...
